Skip to main content

Table 2 ED visits, hospitalizations, and deaths after COVID-19 diagnosis (propensity score–matched study cohorts)

From: Patients with allergic asthma have lower risk of severe COVID-19 outcomes than patients with nonallergic asthma

Outcome, n (%)a

Nonallergic asthma (n = 1578)

Allergic asthma (n = 1578)

P value

Death from any cause

38 (2.4)

19 (1.2)

0.0111

Death from any cause within 30 days of index date

32 (2.0)

14 (0.9)

0.0266

Time to death (days), mean (SD)b

22.1 (38.0)

19 (26.7)

0.2887

 ≥ 1 ED visit or hospitalization

500 (31.7)

392 (24.8)

 < 0.0001

   ≥ 1 ED visit

280 (17.7)

243 (15.4)

0.0765

   ≥ 1 hospitalization

289 (18.3)

217 (13.8)

0.0006

    Death from any cause in those with ≥ 1 hospitalization

29 (10.0)

7 (3.2)

0.0032

    Death within 30 days in those with ≥ 1 hospitalization

24 (8.3)

7 (3.2)

0.0083

  1. COVID-19 coronavirus disease 2019, ED emergency department
  2. a Unless otherwise stated
  3. b For patients who died